Your browser doesn't support javascript.
loading
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.
Shibuya, Kendall C; Goel, Vikas K; Xiong, Wei; Sham, Jonathan G; Pollack, Seth M; Leahy, Allison M; Whiting, Samuel H; Yeh, Matthew M; Yee, Cassian; Riddell, Stanley R; Pillarisetty, Venu G.
Afiliación
  • Shibuya KC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Goel VK; Department of Surgery, University of Washington, Seattle, Washington, United States of America.
  • Xiong W; Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Sham JG; Department of Surgery, University of Washington, Seattle, Washington, United States of America.
  • Pollack SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Leahy AM; Surgical Oncology, Seattle Cancer Care Alliance, Seattle, Washington, United States of America.
  • Whiting SH; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Yeh MM; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washington, United States of America.
  • Yee C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Pillarisetty VG; Department of Surgery, University of Washington, Seattle, Washington, United States of America.
PLoS One ; 9(5): e96565, 2014.
Article en En | MEDLINE | ID: mdl-24794217
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Páncreas / Adenocarcinoma / Terapia Neoadyuvante / Carcinoma Ductal Pancreático / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Páncreas / Adenocarcinoma / Terapia Neoadyuvante / Carcinoma Ductal Pancreático / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos